primary:Many of these
disorders are
hereditary/secondary:
acquired immunodeficiencies,
can result from various
immunosuppressive agents,
for example, malnutrition,
aging and particular
medications
When to suspect? >1 septicaemia, >1
meningitis, >1 pneumonia, >5 chest
infections -because usually cleared by
immune system. Unusual
infections=mycobacterium avium,
pneumocystis carinii, invasive candida
Phagocyte
immunodeficiencies
Neurtropenia- not enough neutrophils, primary:
congenital neutropenia. Secondary e.g. chemotherapy
Chronic granulomatous disease- phagocytes unable
to kill certain organisms (bacteria-staphylococcus
aureus/fungi-aspergillus fumigatus).
Phagocyte killing by
respiratory
burst=Reaction equation
Defective phagocyte killing-
failure of phagocytes to kill
ingested microbes due to
defective production of free
radicals & other toxic molecules.
Rare disease, usually diagnosed in
infancy. Patients experience
recurrent infections (bacterial and
fungal) not normally observed in
healthy patients. Antimicrobial drugs
and IFNy used for CGD treatment
Defects caused by mutations in
subunits of the superoxide generating
NADPH-oxidase enzyme. X-linked
form most common-effects gp91
subunit of NAPHH oxidase. Other
forms are autosomal
recessive-affects other subunits
Leucocyte
adhesion deficiency
Rare disease. Phagocytes unable to migrate to tissues,
blood cells build up in blood, patients susceptible to most
bacterial and fungi. Defect with molecule LFA-1 (CD18)
Complement
deficiencies
Defects in early C proteins (C1, C2,C4)=autoimmune
diseases-SLE very common & sometimes RA
Defects in MAC formation (C5-C9)- neisseria
assocated meningococcal disease & gonorrhoea
Properdin deficiency (activates alt pathway)-neisseria
associated meningococcal disease
MBL deficiency (lectin pathway)-resp infections
in children & autoimmune problems
MBL is polymorphic-this genetic variation
confers differing MBL levels. Range from 5ng/ml
to 10 in serum. Atleast 5% of popn have low
MBL haplotype-not strongly associated with
increased disease susceptibility like many other
immunodeficicncies- illustrates redundancy in
immune sys-because have classical pathway
still so not serious effects. Risk of infection
greater in young children especially during the
'window of vulnerability' prior to maturation of
adaptive immunity. Association with autoimmune
diseases suggests a complex reg role of MBL.
Treatment: MBL replacement therapy.
Regulatory defects- cascade overactivated
where it shouldnt be: Clq inhibitor defect-
hereditary angioedema/ DAf
deficiency-paroxysmal nocturnal
hemoglobinuria (spont. RBC lysis)/ Factor H
deficiency-various renal complications
Macrophage activation defects
Macrophage infected with bacteria signal to T cells (IL-12)
which then signal the macrophage to kill the bacteria (IFNy)
IFNy binds IFNy receptor-activates Jack/STAT
pathway of signalling molecule-switches on txn
of interferon responsive genes
Type I cytokine deficiency-
salmonella, mycobacterial disease
(which live inside the macrophage)
IFNy defects
mutation of IFN y receptor-autosomal
recessive (must have defect on both
copies), common in inbred families. Patients
do not display increased susceptiblity to
other intracellular pathogens suggests IFNy
signalling has crucial role in immunity against
mycobacteria. Observed mostly in young
children
IL-12 defects
Mutation of IL-12 receptor causes
inability to respond to IL12=defective IL12
production. Presents at variable ages
STAT1 defects- mutated STAT1 txn
factor-defective IFNy respnses (usually triggers
production of interferon response genes)
Antibody deficiency
Bacterial infections and viral
infections to a smaller extent (except enterovirus)
Spleen
Blood filter-removes damaged red cells, stores platelets,
immune responses-major secondary lymphoid organ
Asplenia (acquired)=due to splenectomy to correct
abnormal splenic function=englarged spleen in malaria,
some leukaemia's and lymphomas, car crash.
Removal of spleen requires follow up vaccination
SCID-severe
combined
immunodeficiency
Defects affect wither T cells or T
cells & B cells. Patients have very
low lymphocyte numbers, normal
RBC & myeloid cells= Lack of T cell
responses, B cell defects can be
masked by presence of maternal
Abs, severe infections (viral &
fungal)-usually lethal, confinement of
patient to sterile environment usually
required, treated by stem cell
transplantatio (restore cells with
infective genes)
Can be due to mutations in no. of
important genes: IL=2Ry chain gene, JAK3
deficiency, RAG-1/-2 genes/ ZAP-70
CVID-common
variable
immunodeficiency
B cell disorder. Low Ab levels
(IgM,IgG,IgA)-hypogammaglobulinemia.
Recurrent infections usually later in life. Genetic
defects not fully defined. Defective maturation of
B cells into plasma cells or defect in Ab
production. Treatment by immunoglobin therapy
XLA-X linked agammaglobulinemia
More common in males, male patient will pass on
the gene to any daughters-with one abnormal
copy=carriers but their sons at risk. Deficiency in
B cells. Mutation in BTk gene-affects B cell
development. Recurrent infections. Even live
attenuated vaccines cannot be handled by XLA
patients. Treated by immunoglobulin therapy
AIDS
Epidemic. HIV-1 )RNA virus). Patients
display symptoms of opportunistic
infections-TB, malaria, pneumonia or
cancer. Decrease in CD4+ T cells. HIV-1
attached to and infect CD4+ T cells=form
syncytia (giant cells)-infected T cells are
rapidly killed. Defective delayed type
hypersensivity to Ag. Elevated IgG & IgA
production, reduced IgM